Zoetis to Participate in the Goldman Sachs 37th Annual Global Healthcare Conference

. (NYSE:ZTS) will participate in the Goldman Sachs
37th Annual Global Healthcare Conference on Tuesday, June 7, 2016, in
Rancho Palos Verdes, Calif. Paul Herendeen, Executive Vice President and
Chief Financial Officer, will represent the company and respond to
questions from analysts. He is scheduled to present at 2:20 p.m. EDT
(11:20 a.m. PDT).

Investors and other interested parties will be able to access a live
audio webcast of the presentation by visiting http://investor.zoetis.com/events-presentations.
A replay of the presentation will also be available on the Zoetis
website at the conclusion of the event.

About Zoetis

Zoetis (zô-EH-tis) is the leading animal
health company, dedicated to supporting its customers and their
businesses. Building on more than 60 years of experience in animal
health, Zoetis discovers, develops, manufactures and markets veterinary
vaccines and medicines, complemented by diagnostic products and genetic
tests and supported by a range of services. Zoetis serves veterinarians,
livestock producers and people who raise and care for farm and companion
animals with sales of its products in more than 100 countries. In 2015,
the company generated annual revenue of $4.8 billion with approximately
9,000 employees. For more information, visit www.zoetis.com.


Forward-Looking Statements: This
press release contains forward-looking statements, which reflect the
current views of Zoetis with respect to business plans or prospects,
future operating or financial performance, future guidance, future
operating models, expectations regarding products, future use of cash
and dividend payments, tax rate and tax regimes, changes in the tax
regimes and laws in other jurisdictions, and other future events. These
statements are not guarantees of future performance or actions.
Forward-looking statements are subject to risks and uncertainties. If
one or more of these risks or uncertainties materialize, or if
management’s underlying assumptions prove to be incorrect, actual
results may differ materially from those contemplated by a
forward-looking statement. Forward-looking statements speak only as of
the date on which they are made. Zoetis expressly disclaims any
obligation to update or revise any forward-looking statement, whether as
a result of new information, future events or otherwise. A further list
and description of risks, uncertainties and other matters can be found
in our Annual Report on Form 10-K for the fiscal year ended December 31,
2015, including in the sections thereof captioned “Forward-Looking
Information and Factors That May Affect Future Results” and “Item 1A.
Risk Factors,” in our Quarterly Reports on Form 10-Q and in our Current
Reports on Form 8-K. These filings and subsequent filings are available
online at 
or on request from Zoetis.


Zoetis Inc.
White, 1-973-443-2835 (o)
Seely, 1-973-443-2777 (o)
O’Connor, 1-973-822-7088 (o)
Frank, 1-973-822-7141 (o)